73
ENGSTRÖM-LAURENT, A.; LOOF, L. Increased serum levels of hyaluronate in liver
disease. Hepatology, Philadelphia, v.5: p.638-642, 1985.
ESPINOSA, M.; RODRIGUEZ, M.; MARTÍN-MALO, A. Interferon therapy in
hemodialisis patients with chronic hepatitis C infection induces a high rate of long-term
sustained virological and biochemical response. Clin Nephrol, Mexico, v.55: p.220-226,
2001.
FABRIZI, F. et al. Nosocomial transmission of hepatitis C virus infection in hemodialysi
patients: Clinical perspectives. Int J Artif Organs, Oslo, v.23, p.805-816, 2000.
FABRIZI, F.; POORDAD, F.F.; MARTIN, P. Hepatitis C infection and the patient with end-
stage renal disease. Hepatology, Philadelphia, v.36: p.3-10, 2002.
FABRIZI, F. et al. Meta-analysis: Interferon for the treatment of chronic hepatitis C in
dialysis patients. Aliment Pharmacol Ther, London, v.18: p.1071-1081, 2003.
FABRIZI, F.; MARTIN, P.; BUNNAPRADIST, S. Treatment of chronic viral hepatitis in
patients with renal disease. Gastroenterol Clin N Am, Washington, v.33: p.655-670, 2004.
FARCI, P. et al. The outcome of acute hepatitis C predcted by the evolution of the viral
quasispecies. Science, Washington, v.288: p.339-334, 2000.
FISSELL, RB.; BRAGG-GRESHAM, JL.; WOODS, JD.; JADOUL, M.; GILLESPIE, B.;
HEDDERWICK, AS.; PAYNER, HC.; GREENWOOD, RN.; AKIBA, T.; YOUNG, EW.
Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three
continents: the DOPPS. Kid Int, Massachusetts,v.65: p.2335-2342
FRANÇA, J.L. et al. Manual para normalização de publicações técnico-científicas. Belo
Horizonte: UFMG, 8a. edição, 2007.
FRASER J.R.; LAURENT, T.C.; LAURENT, U.B.G. Hyaluronan: its nature, distribution,
functions and turnover. J Int Med, London, v.242, n.1: p.27-33, 1997.
FRIEDMAN, S.L. Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic
implication. Nat Clin Pract, Oxford, v.1, n.2: p.98-105, 2004.
FURUSYO, N. et al. Liver damage in hemodialysis patients with hepatitis C virus viremia:
A prospective 10- year study. Dig Dis Sci, New York, v.45: p.2221-2228, 2000.
GERDIN, B.; HALLGREN, R. Dynamic role of hyaluronan (HYA) in connective tissue
activation and inflammation. J Int Med, London, v.242, n.1: p.49-55, 1997.
GIBB, D.M.; GOODALL, R.L.; DUNN, D.T. Mother-to-child transmission of hepatitis C
virus: evidence for preventable peripartum transmission. Lancet, London, v.356: p.904-907,
2000.
GONZÁLES-RONCERO, F. et al. Outcome of kidney tranplant in chronic hepatitis C vírus
patients: effect of pretransplantation interferon-alpha 2b monotherapy. Transplant Proceed,
[s.l.], v.35: p.1745-1747, 2003.